How Prolotherapy Works: What a Dextrose Injection Actually Starts, and How It Differs From PRP

How Prolotherapy Works: What Happens After the Dextrose Goes In

The question I hear most often in clinic is some version of "what good does sugar water do?" It is a fair question. Dextrose solution contains no collagen, no growth factors and nothing that lubricates a joint. There is no repair material in the syringe at all. So if it helps, the reason is not in the bottle. It is in how your body answers it.

Prolotherapy (injection treatment that works by provoking a local repair response) is built on exactly that idea. Understanding the mechanism pays off in practical ways: you will see why the treatment is spread over several sessions, why the area can ache for a day or two afterwards, and why it sits alongside PRP rather than competing with it.

What a dextrose injection actually does

The solution, a concentrated dextrose preparation, is placed into the problem ligament, the tendon attachment, or the joint space. The concentration is far above that of blood, and clinically used strengths run roughly from five to twenty-five percent depending on the site and the goal.

What decides the outcome is placement. A ligament or tendon lesion is often only a few millimetres across, with vessels and nerves right beside it. Inject blind and the fluid may simply sit in fat, where nothing happens at all. So these injections are done under high-resolution ultrasound guidance: see the lesion and the structures around it first, then decide the needle path.

Key point: The benefit is produced by your own repair response. Where the fluid ended up usually decides more than which solution went in.

The osmotic story picked up an important footnote

Almost every explanation online runs the same way. Concentrated dextrose is strongly hypertonic, so the cells it touches lose water and sustain minor injury; the body reads that as a wound, starts an inflammatory response, recruits repair cells, releases growth factors, and lays down new collagen.

The direction is right, but this is not settled science. In their narrative review of the basic science and clinical research, Reeves and colleagues state plainly that the mechanism of action is not clearly known and is likely to be multifactorial (PMID: 27788902, DOI 10.1016/j.pmr.2016.06.001).

The more interesting part is what happens inside a joint. Reeves and colleagues ran a single-participant study on themselves: dextrose was injected into knees without knee pathology, then joint fluid was aspirated repeatedly to track concentration. Across three trials the concentration fell quickly, close to an exponential curve. Their conclusion was that the cells, tissues and structures inside the joint are exposed to a high dextrose concentration only very briefly (PMID: 40002763, DOI 10.3390/biomedicines13020350).

That matters because laboratory work has often kept cells bathed in high-concentration dextrose for long stretches, which may not resemble what a real joint experiences. As an explanation for intra-articular injection, "osmotic pressure injures the cells" carries less weight than it used to, and something else is probably also at work.

Key point: An unfinished mechanism is the honest state of this field. What it means for you is simple: do not judge whether the treatment is working by how sore or inflamed the area feels afterwards. That signal is not reliable.

Why ligaments, tendons and joint capsules

Ligaments and tendons have a thin blood supply to begin with, so they heal slowly. An acute strain usually settles on its own. The awkward cases are the ones that have dragged on for months, where the tissue has already shifted toward degeneration and the body seems to have filed the injury away and stopped working on it. Prolotherapy is an attempt to put it back on the list.

Situations where it commonly comes up include knee osteoarthritis, tendon attachment problems such as tennis and golfer's elbow, plantar fasciitis, shoulder tendon and rotator cuff problems, sacroiliac and low back ligament laxity, and long-standing neck and shoulder myofascial pain. For the knee, knowing roughly which stage of degeneration you are at helps a great deal; the staging guide covers that in more detail.

If you would rather start with the whole range of options and how they are sequenced, begin with regenerative and pain treatment.

How it differs from PRP, and when the two work together

Both aim at the same thing, tissue repair. They take different routes there.

What sets the order is the nature of the lesion, the state of the tissue and what you want to get back to. For ligament laxity and attachment-point problems, dextrose prolotherapy is a common starting point. Where intra-articular degeneration is more pronounced, or where the first few sessions do less than expected, PRP comes into the conversation. They can also share one treatment plan, working on different layers and sites.

For a closer comparison of three common injections, this article goes into more depth.

What a course of treatment looks like

Assessment comes first. History plus ultrasound, to confirm the pain really is coming from a ligament, tendon or joint rather than a nerve compression or something else wearing that disguise. Skip this step and precise injection later buys you nothing.

Then the schedule. The usual pattern is several sessions spaced some weeks apart, leaving the tissue time to respond and rebuild, with adjustments based on how you are doing at follow-up. On the day and the day after, the injected area may feel sore and full; that is within expectations. Hard training is worth postponing for a few days, but complete rest is not the safer option, because tissue reorganises better along normal lines of load. Ordinary daily activity can continue.

How quickly and how much you feel varies with individual tissue response. For knee osteoarthritis the accumulated literature is broadly positive on pain and function; in the same breath it has to be said that injection protocols and study designs differ a great deal between trials and follow-up is mostly short, so a standardised protocol is still being worked out (PMID: 40831953, DOI 10.3389/fendo.2025.1602727). That is why the plan follows your response at follow-up rather than running a fixed script.

Situations that need sorting out first

Some circumstances need attention or exclusion before any injection is scheduled:

• Infection at the injection site or systemically
• A clotting disorder, or current anticoagulant medication
• Pregnancy
• Malignancy, or a lump of unclear origin, in the area to be injected
• Diabetes with unstable glucose control (dextrose is what goes in, so discuss it with your doctor first)

Separately, these call for medical assessment before anyone thinks about injections: fever with a hot, red, swollen joint; inability to bear weight after an injury; night pain that is clearly worsening; a joint that suddenly locks or gives way; unexplained weight loss. Those signals point somewhere else. When joint pain needs a doctor helps with that judgement, and who regenerative treatment suits covers indications and contraindications in full.

Common questions

Does prolotherapy always hurt?

There is a sense of pressure during the injection, and the area may ache for a day or two afterwards. How sore it gets does not track with how well it works, which is a common misunderstanding. Some people feel almost nothing and still improve; others ache for two days and recover no faster.

Why can't it all be done in one session?

Because repair happens in stages. Tissue needs time to respond, rebuild and realign. Injections spaced too closely just hit the same stage twice, which does not double the progress. That is why a course is spread out and adjusted at follow-up.

Can I have prolotherapy if I am diabetic?

It depends on how stable your glucose control is. Dextrose is the injected substance, and although the amount has limited bearing on systemic glucose, unstable control still calls for careful assessment. Bring up your history and medication at the consultation.

Can I exercise afterwards?

Hold off on hard training and impact sport for a few days. Walking, stretching and light activity are not only allowed but helpful, because they guide the tissue to reorganise along normal lines of load. Total rest is not the safer choice.

How do I choose between prolotherapy, hyaluronic acid and steroid injection?

They do different jobs: steroid suppresses inflammation, hyaluronic acid improves lubrication, prolotherapy drives repair. The choice follows the stage of degeneration and your main symptom, and often they are combined. This comparison covers the detail.

References

1. Reeves KD, Sit RW, Rabago DP. Dextrose Prolotherapy: A Narrative Review of Basic Science, Clinical Research, and Best Treatment Recommendations. Phys Med Rehabil Clin N Am. 2016;27(4):783-823. PMID: 27788902. DOI: 10.1016/j.pmr.2016.06.001
2. Reeves KD, Atkins JR, Solso CR, et al. Rapid Decrease in Dextrose Concentration After Intra-Articular Knee Injection: Implications for Mechanism of Action of Dextrose Prolotherapy. Biomedicines. 2025;13(2):350. PMID: 40002763. DOI: 10.3390/biomedicines13020350
3. Huang K, Cai H. Hypertonic dextrose prolotherapy in osteoarthritis: mechanisms, efficacy, and future research directions. Front Endocrinol. 2025;16:1602727. PMID: 40831953. DOI: 10.3389/fendo.2025.1602727

This article is patient education covering general principles and clinical considerations. It cannot replace an in-person examination. To find out whether your own situation is suitable and where to start, you are welcome to arrange an online consultation and individual assessment.